What is the maximum recommended dose of midazolam (Benzodiazepine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Recommended Dose of Midazolam

The maximum dose of midazolam varies significantly by route, indication, and patient population, but for acute intermittent dosing in adults, single doses should not exceed 5 mg IV/SC per administration, with total procedural doses typically capped at 10 mg. 1, 2

Adult Dosing Maximums by Clinical Context

Acute Agitation/Delirium Management

  • Maximum single dose: 5 mg subcutaneous or intravenous, administered every 1 hour as needed 1
  • In elderly, frail, or COPD patients, or when combined with antipsychotics, reduce maximum to 0.5-1 mg per dose due to synergistic respiratory depression risk 1, 3
  • When combined with opioids, reduce all doses by at least 20% due to dramatically increased respiratory depression risk 3

Procedural Sedation

  • Initial dose: 0.05-0.1 mg/kg IV (typically 2.5-5 mg in adults under 60 years) 3, 2
  • Maximum single dose: 5 mg 2
  • Total procedural dose: typically does not exceed 10 mg 2
  • Titrate slowly over 2-3 minutes, waiting an additional 2-3 minutes between doses to evaluate effect before repeating 2

ICU Continuous Infusion

  • Maintenance infusion: 0.02-0.1 mg/kg/hr (approximately 1-7 mg/hr initially for a 70 kg patient) 3
  • Higher range studies report up to 0.086 mg/kg/hr (approximately 6 mg/hr for 70 kg patient) 3
  • For breakthrough agitation, bolus doses equal to 1-2 times the hourly infusion rate every 5 minutes as needed 3
  • If 2 boluses required within 1 hour, double the infusion rate 3

Status Epilepticus/Refractory Seizures

  • Loading dose: 0.15-0.20 mg/kg IV (approximately 7.5-10 mg for 70 kg patient) 3
  • Continuous infusion: start at 0.06 mg/kg/hr (3 mg/hr for 70 kg patient), titrate up to maximum 0.3 mg/kg/hr (approximately 21 mg/hr for 70 kg patient) 3, 4

Pediatric Dosing Maximums

Procedural Sedation (Non-Intubated)

  • Ages 6 months-5 years: Initial 0.05-0.1 mg/kg; total dose up to 0.6 mg/kg maximum (usually not exceeding 6 mg total) 2, 5
  • Ages 6-12 years: Initial 0.025-0.05 mg/kg; total dose up to 0.4 mg/kg maximum (usually not exceeding 10 mg total) 2, 5
  • Ages 12-16 years: Dose as adults; total dose usually does not exceed 10 mg 2

Seizure Management

  • Intranasal/IM route: 0.2 mg/kg (maximum 6 mg per dose), may repeat every 10-15 minutes 4
  • IV route: 0.05-0.10 mg/kg (maximum single dose 5 mg), may repeat every 10-15 minutes 4
  • Refractory seizures infusion: Maximum 5 μg/kg/min (0.3 mg/kg/hr) 4

ICU Sedation (Intubated Pediatric Patients)

  • Loading dose: 0.05-0.2 mg/kg over 2-3 minutes 2
  • Continuous infusion: 0.06-0.12 mg/kg/hr (1-2 mcg/kg/min) 2

Neonatal ICU Sedation (Intubated)

  • No loading dose recommended in neonates 2
  • <32 weeks gestation: 0.03 mg/kg/hr (0.5 mcg/kg/min) 2
  • >32 weeks gestation: 0.06 mg/kg/hr (1 mcg/kg/min) 2

Critical Dose Reduction Requirements

Hepatic or Renal Impairment

  • Reduce dose by at least 20% due to decreased clearance 3
  • Drug elimination is significantly delayed in liver dysfunction 2

Drug Interactions Requiring Dose Reduction

  • Concurrent opioids: reduce by at least 20% due to synergistic respiratory depression 3
  • H2-receptor antagonists: reduce dose due to 30% increased bioavailability 3
  • Erythromycin or P450-3A4 inhibitors: significantly delayed elimination requires dose reduction 2

Age-Related Adjustments

  • Elderly patients: Use lower end of dosing range; maximum single dose often 0.5-1 mg 1, 3
  • Infants <6 months: Titrate with small increments; dosing recommendations unclear due to transitional physiology 2

Critical Safety Warnings

Respiratory Depression Risk

  • Respiratory depression can occur up to 30 minutes after administration 3, 6
  • Flumazenil must be available for reversal, though its 1-hour duration may be shorter than midazolam's effect, requiring monitoring for re-sedation 6
  • Apnea risk is highest when combined with other sedatives, particularly in children and elderly 4, 7

Common Dosing Errors to Avoid

  • Underdosing is frequent in emergency settings: 92% of adults and 56% of children receive less than the minimum recommended 0.1 mg/kg for RSI 8
  • Rapid IV administration causes oversedation and hypotension: always administer over 2-3 minutes and wait additional 2-3 minutes to evaluate effect 4, 2
  • High-dose protocols (>10 mg repeated doses) are not more effective and increase risk of prolonged sedation and airway complications 9

Hemodynamic Monitoring

  • Hypotension occurs particularly in critically ill patients, those receiving opioids, or with rapid administration 2
  • In hemodynamically compromised patients, titrate loading doses in small increments and monitor continuously 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Midazolam Dosing and Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Midazolam Dosing for Febrile Convulsions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Benzodiazepine Conversion and Sedation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Underdosing of midazolam in emergency endotracheal intubation.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.